Preventive misconception and adolescents' knowledge about HIV vaccine trials

Journal of Medical Ethics

Volumn 39, Issue 12, 2013, Pages 765-771

  Ott, Mary A ^a   Alexander, Andreia B ^a   Lally, Michelle ^b   Steever, John B ^c   Zimet, Gregory D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ATTITUDE TO HEALTH; COMPREHENSION; DECISION MAKING; ETHICS; FEMALE; HIV INFECTIONS; HUMAN; IMMUNOLOGY; MALE; MEDICAL RESEARCH; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH ETHICS; RESEARCH SUBJECT; SEXUAL BEHAVIOR; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADOLESCENT DEVELOPMENT; AIDS VACCINES; BIOMEDICAL RESEARCH; COMPREHENSION; DECISION MAKING; ETHICS, RESEARCH; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUBJECTS; SEXUAL BEHAVIOR; VACCINATION; YOUNG ADULT;

EID: 84890133032     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2012-100821     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention DoHAP, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. HIV/AIDS surveillance report: cases of HIV infection and AIDS in the United States and dependent areas, 2009. Atlanta, GA: U.S. Department of Health and Human Services, 2011.
2. Padian NS, McCoy SI, Karim SS, et al. HIV prevention transformed: the new prevention research agenda. Lancet 2011;378:269-78.
3. Bryant J, Baxter L, Hird S. Non-occupational postexposure prophylaxis for HIV: a systematic review. Health Technol Assess 2009;13:iii, ix-x, 1-60.
4. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-99.
5. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.
6. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009;361:2209-20.
7. Simon AE, Wu AW, Lavori PW, et al. Preventive misconception: its nature, presence, and ethical implications for research. Am J Prev Med 2007;32:370-4.
8. Eaton LA, Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep 2007;4:165-72.
9. Slack C, Kruger M. The South African Medical Research Council's Guidelines on Ethics for Medical Research-implications for HIV-preventive vaccine trials with children. S Afr Med J 2005;95:269-71.
10. Centers for Disease Control and Prevention. HIV prevention in the third decade. Altanta, GA: U.S. Department of Health and Human Services, 2005.
11. Neely MN, Rakhmanina NY. Pharmacokinetic optimization of antiretroviral therapy in children and adolescents. Clin Pharmacokinet 2011;50:143-89.
12. Giuliano AR, Lazcano-Ponce E, Villa L, et al. Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine. J Infect Dis 2007;196:1153-62.
13. Abma J, Martinez G, Copen C. Teenagers in the United States: sexual activity, contraceptive use and childbearing, national survey of family growth 2006-2008. Vital Health Stat 2010;23:1-47.
14. Giordano PC, Manning WD, Longmore MA. Adolescent romantic relationships: an emerging portrait of their nature and developmental significance. In: Crouter AC, Booth A, eds. Romance and sex in adolescence and emerging adulthood: risks and opportunities. Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers, 2006:127-50.
15. Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance-United States, 2011. MMWR Surveill Summ 2012;61:1-162.
16. U.S. Department of Health & Human Services. 45 CFR 46, Subpart D. Protection of Human Subjects, Additional Protections for Children Involved as Subjects in Research. Code of Federal Regulations, 2005.
17. Shaddy RE, Denne SC. Clinical report-guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics 2010;125:850-60.
18. Ford C, English A, Sigman G. Confidential health care for adolescents: position paper for the society for adolescent medicine. J Adolesc Health 2004;35:160-7.
19. Rudy BJ, Kapogiannis BG, Lally MA, et al. Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials. J Acquir Immune Defic Syndr 2010;54(Suppl 1):S31-42.
20. Hosek SG, Zimet GD. Behavioral considerations for engaging youth in HIV clinical research. J Acquir Immune Defic Syndr 2010;54(Suppl 1):S25-30.
21. Kapogiannis BG, Lee SS. Rolling up our sleeves now to reap the benefits later: preparing the community for an adolescent HIV vaccine. Current Opinion in HIV and AIDS 2007;2:375-84.
22. McClure C, Gray G, Rybczyk G, et al. Challenges to conducting HIV preventative vaccine trials with adolescents. J Acquir Immune Defic Syndr (1999) 2004;36:726-33.
23. Swartz L, Kagee A, Kafaar Z, et al. Social and behavioral aspects of child and adolescent participation in HIV vaccine trials. J Int Assoc Physicians AIDS Care (Chic Ill) 2005;4:89-92.
24. Blake DR, Lemay CA, Kearney MH, et al. Adolescents' understanding of research concepts: a focus group study. Arch Pediatr Adolesc Med 2011;165:533-9.
25. de Bruyn G, Skhosana N, Robertson G, et al. Knowledge and attitudes towards HIV vaccines among Soweto adolescents. BMC Res Notes 2008;1:76.
26. Giocos G, Kagee A, Swartz L. Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents. AIDS and Behavior 2008;12:842-51.
27. Mattson CL, Campbell RT, Bailey RC, et al. Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS One 2008;3:e2443.
28. Martin JN, Roland ME, Neilands TB, et al. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS 2004;18:787-92.
29. Bartholow BN, Buchbinder S, Celum C, et al. HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2005;39:90-101.
30. Buchbinder SP, Mehrotra DV, Duerr A, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008;372:1881-93.
31. Maxwell JA. Qualitative research design: an interactive approach. Thousand Oaks, CA: Sage Publications, Inc, 2005.
32. Strauss AL, Corbin JM. Basics of qualitative research: techniques and procedures for developing grounded theory. 2nd edn. Thousand Oaks: Sage Publications, 1998.
33. Kuther TL, Posada M. Children and adolescents' capacity to provide informed consent for participation in research. Adv Psychol Res 2004;32:163-73.
34. Weithorn L, Campbell S. The competency of children and adolescents to make informed treatment decisions. Child Development 1982;53:1589-98.
35. Steinberg L. A social neuroscience perspective on adolescent risk-taking. Dev Rev 2008;28:78-106.
36. Yurgelun-Todd D. Emotional and cognitive changes during adolescence. Curr Opin Neurobiol 2007;17:251-7.
37. Peters E, Hibbard J, Slovic P, et al. Numeracy skill and the communication, comprehension, and use of risk-benefit information. Health Aff (Millwood) 2007;26:741-8.
38. Nelson W, Reyna V, Fagerlin A, et al. Clinical implications of numeracy: theory and practice. Ann Behav Med 2008;35:261-74.